Loading company…
ID 402265311 · FY 2023–2024 · 2 years
კომპანიის ძირითად საქმიანობას წარმოადგენს სამედიცინო და ორთოპედიული საქონლით საცალო ვაჭრობა სპეციალიზებულ მაღაზიებში.
Bars are revenue on the left axis; lines are EBITDA and net margin on the right.
| Line item | 2023 | 2024 | CAGR |
|---|---|---|---|
| Total Revenue | 2,816 | 3,411 | +21.1% |
| Total COGS | -2,261 | -2,791 | +23.4% |
| Gross Profit | 554 | 620 | +11.8% |
| Gross Margin | 19.7% | 18.2% | |
| Total Operating Expenses | -478 | -631 | +32.0% |
| EBITDA | 76 | -12 | nmf |
| EBITDA Margin | 2.7% | -0.3% | |
| Total D&A | 0 | 0 | |
| EBIT / Operating Income | 76 | -12 | nmf |
| Total Other Income | -48 | -36 | -24.6% |
| Profit Before Tax | 28 | -48 | nmf |
| Total Income Tax | 0 | 0 | |
| Net Profit / (Loss) | 28 | -48 | nmf |
| Net Margin | 1.0% | -1.4% |
Shareholders, directors and group links from the companyinfo.ge public register — as filed, so stakes need not sum to 100% where a holding is undisclosed.
Companies sharing this sub-sector, ranked by how close their latest revenue is to this one — not a curated comp set.
* Free cash flow = OCF − net investing outflow (the filings carry no standalone capex line).
Ownership & directors from companyinfo.ge (public corporate registry).